These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12238937)

  • 21. Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site.
    Venäläinen JI; Juvonen RO; Garcia-Horsman JA; Wallén EA; Christiaans JA; Jarho EM; Gynther J; Männistö PT
    Biochem J; 2004 Sep; 382(Pt 3):1003-8. PubMed ID: 15217351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of prolyl endopeptidase inhibitors and evaluation of their structure-activity relationships: in vitro inhibition of prolyl endopeptidase from canine brain.
    Arai H; Nishioka H; Niwa S; Yamanaka T; Tanaka Y; Yoshinaga K; Kobayashi N; Miura N; Ikeda Y
    Chem Pharm Bull (Tokyo); 1993 Sep; 41(9):1583-8. PubMed ID: 8221972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of prolyl oligopeptidase by Fmoc-aminoacylpyrrolidine-2-nitriles.
    Li J; Wilk E; Wilk S
    J Neurochem; 1996 May; 66(5):2105-12. PubMed ID: 8780042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of novel (123)I-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo.
    Kallinen A; Todorov B; Kallionpää R; Bäck S; Sarparanta M; Raki M; García-Horsman JA; Bergström KA; Wallén EA; Männistö PT; Airaksinen AJ
    Eur J Med Chem; 2014 May; 79():436-45. PubMed ID: 24763264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and inhibitory activity of acyl-peptidyl-pyrrolidine derivatives toward post-proline cleaving enzyme; a study of subsite specificity.
    Saito M; Hashimoto M; Kawaguchi N; Shibata H; Fukami H; Tanaka T; Higuchi N
    J Enzyme Inhib; 1991; 5(1):51-75. PubMed ID: 1669438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.
    Babkova K; Korabecny J; Soukup O; Nepovimova E; Jun D; Kuca K
    Future Med Chem; 2017 Jun; 9(10):1015-1038. PubMed ID: 28632451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of caffeoyl and cinnamoyl derivatives as potential prolyl oligopeptidase inhibitors.
    Adolpho LO; Marin D; Puigpinos A; Mendieta L; Tarragó T; Morel AF; Giralt E; Dalcol II
    Planta Med; 2013 Nov; 79(16):1531-5. PubMed ID: 24085498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural product berberine is a human prolyl oligopeptidase inhibitor.
    Tarrago T; Kichik N; Seguí J; Giralt E
    ChemMedChem; 2007 Mar; 2(3):354-9. PubMed ID: 17295371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoquinoline alkaloids as prolyl oligopeptidase inhibitors.
    Cahlíková L; Hulová L; Hrabinová M; Chlebek J; Hošťálková A; Adamcová M; Šafratová M; Jun D; Opletal L; Ločárek M; Macáková K
    Fitoterapia; 2015 Jun; 103():192-6. PubMed ID: 25863351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.
    Prades R; Munarriz-Cuezva E; Urigüen L; Gil-Pisa I; Gómez L; Mendieta L; Royo S; Giralt E; Tarragó T; Meana JJ
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):180-191. PubMed ID: 27986355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors.
    Venäläinen JI; Garcia-Horsman JA; Forsberg MM; Jalkanen A; Wallén EA; Jarho EM; Christiaans JA; Gynther J; Männistö PT
    Biochem Pharmacol; 2006 Feb; 71(5):683-92. PubMed ID: 16405869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
    Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
    Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of novel chemical scaffolds targeting prolyl oligopeptidase for neurological therapeutics.
    Kumar R; Parameswaran S; Bavi R; Baek A; Son M; Rampogu S; Park C; Lee G; Zeb A; Parate S; Rana RM; Lee KW
    J Mol Graph Model; 2019 May; 88():92-103. PubMed ID: 30665156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel inhibitors of prolyl endopeptidase: effects of stereochemistry.
    Kolosko N; Bakker AV; Faraci WS; Nagel AA
    Drug Des Discov; 1994 Jan; 11(1):61-71. PubMed ID: 8068820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzimidazolium salts as small, nonpeptidic and BBB-permeable human prolyl oligopeptidase inhibitors.
    Tarragó T; Masdeu C; Gómez E; Isambert N; Lavilla R; Giralt E
    ChemMedChem; 2008 Oct; 3(10):1558-65. PubMed ID: 18792035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poststatin, a new inhibitor of prolyl endopeptidase. V. Endopeptidase inhibitory activity of poststatin analogues.
    Tsuda M; Muraoka Y; Nagai M; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1996 Sep; 49(9):890-9. PubMed ID: 8931723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of O-(3-carbamimidoylphenyl)-l-serine amides as matriptase inhibitors using a fragment-linking approach.
    Goswami R; Wohlfahrt G; Mukherjee S; Ghadiyaram C; Nagaraj J; Satyam LK; Subbarao K; Gopinath S; Krishnamurthy NR; Subramanya HS; Ramachandra M
    Bioorg Med Chem Lett; 2015 Feb; 25(3):616-20. PubMed ID: 25556099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitors.
    Cacciola J; Fevig JM; Stouten PF; Alexander RS; Knabb RM; Wexler RR
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1253-6. PubMed ID: 10866393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated parallel synthesis of a tetrahydroisoquinolin-based library: potential prolyl endopeptidase inhibitors.
    Vendeville S; Bourel L; Davioud-Charvet E; Grellier P; Deprez B; Sergheraert C
    Bioorg Med Chem Lett; 1999 Feb; 9(3):437-42. PubMed ID: 10091698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.